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An inhibitory diffusible factor of 45 kDa (IDF45) was isolated from medium conditioned by dense cultures 
of 3T3 cells. The procedure involved Bio-Gel PI50 chromatography and 2 reverse-phase FPLC. After the 
final step of purification, 60 ng/ml of IDF45 inhibited 50% of a-globulin-stimulated DNA synthesis. It was 
shown that IDF45 acted in the Gi phase of the cell cycle. When added for 8 h in the Gi phase of the cell 
cycle, it was able to inhibit DNA synthesis in the S phase which followed this Gi phase. Furthermore, IDF45 
inhibited the early stimulation of RNA synthesis induced by a-globulin. 
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1, INTRODUCTION 
The factors which control the growth of cells in 
culture are poorly understood. We have previously 
shown that 3T3 cell cultures diffuse in the medium 
inhibitory [I,21 and stimulatory [2] factors. We 
assumed [3] that normal cell cultures enter sta- 
tionary phase when the concentration of inhibitory 
molecules in the medium counterbalances 
autocrine and exocrine stimulatory factors. 
Growth inhibitory factors of 45 kDa [2,4,5] have 
been fractionated from medium conditioned by 
dense cultures of 3T3 cells. From this medium a 
growth inhibitory molecule of 13 kDa has been 
recently purified [6]. Growth inhibitory factors 
have also been fractionated or purified from 
medium conditioned by different cell types [7-91. 
Recently however, similarities have been shown 
between the inhibitory molecules diffusing from 
BSCt cells [7] and type &TGF which may be a 
bifunctional regulator of cellular growth [lo- 121. 
In this study, IDF45, the inhibitory molecule of 
45 kDa diffusing from dense cultures of 3T3 cells 
[3,4], has been further purified by reverse-phase 
FPLC. We have shown that IDF45 acts in the Gr 
phase of the cell cycle. The early stimulation by 
growth factors of RNA synthesis [ 13) was 
prevented by IDF45. 
2. MATERIALS AND METHODS 
2.1. Cells 
Swiss 3T3 cells (American Type Culture Collec- 
tion) were grown at 37°C in Dulbecco’s modified 
Eagle Medium (DMEM) containing 5% newborn 
calf serum and antibiotics. 
2.2. Assays of IDF45 activity 
Target 3T3 cells (5 x 10’) were seeded in DME 
medium with 5% serum in 96-well culture plates. 
After 1 day, the medium was discarded and re- 
placed by serum-free medium; 2 days later, the 
lyophilized fractions were solubilized in the serum- 
free medium of the cultures and added with 75 ,ug 
a-globulin to the quiescent target cultures as 
described [5]. cY-Globulin (Cohn Fraction IV 
Flucka) has properties of growth factors (141. At 
this concentration, the stimulation of DNA was 
about 30% of the maximal stimulation induced by 
serum. Except when noted, DNA synthesis was 
determined by labelling the cells with 
[‘4C]thymidine (0.05 &i/well) between 6 and 24 h 
Published by Elsevier Science Publishers B. V. (Biomedical Division) 
00145793/86/$3.50 0 1986 Federation of European Biochemical Societies 175 
Volume 203, number 2 FEBS LETTERS July 1986 
after the addition of fractions. The inhibitory ac- 
tivity of IDF45 was determined by the percent in- 
hibition of stimulation of DNA synthesis by cy- 
globulin. [14C]Thymidine incorporation into the 
cells in the absence of a-globulin was between 12 
and 16% of incorporation in the presence of CY- 
globulin. 
Nucleic acid synthesis was determined by label- 
ling the cells with [r4C]inosine (0.25 &i/well). 
[‘4C]Inosine incorporation into nucleic acids (acid- 
insoluble fraction), RNA and DNA was deter- 
mined as described in [2]. 
2.3. Isolation of IDF45 
Serum-free medium (about 3 1) was conditioned 
by dense cultures of 3T3 cells and macromolecules 
of this medium were concentrated, solubilized in 
acetic acid (1 M) and acid-soluble proteins were 
fractionated over a ‘Bio-Gel P150’ column as 
described [2]. 
The lyophilized fractions containing IDF45 ac- 
tivity were pooled, solubilized in 0.05% TFA 
;trifluoroacetic acid), then adjusted to 17% 
ace’onitrile, 0.05% TFA and fractionated by 
FPLC (Pharmacia). The sample was injected onto 
a CS ProRPC HR5/2 column (Pharmacia). Elution 
was achieved with a linear 35-min gradient of 
17-47% acetonitrile, 0.05% TFA, followed by a 
linear 15-min gradient 47-100% acetonitrile, 
0.05% TFA at a flow rate of 0.3 ml/min. An ali- 
quot of each fraction was lyophilized and tested 
for IDF45 activity. 
Fractions containing IDF45 activity from 
reverse-phase FPLC described above were ad- 
justed to 17% acetonitrile, 0.05% TFA and 
rechromatographed by injection on a Cs ProRPC 
HR 5/10 column (Pharmacia). The column was 
eluted with a linear lo-min gradient of 17-24% 
acetonitrile in 0.05% TFA, followed by a 40-min 
gradient of 24-37% acetonitrile in 0.05% TFA, at 
a flow rate of 0.3 ml/min. Fractions were 
lyophilized. 
2.4. SDS-PAGE 
Lyophilized fractions from FPLC were 
solubilized in an SDS sample buffer (10% glycerol, 
2.3% SDS, 0.0625 M Tris-HCl, pH 6.8). SDS- 
polyacrylamide gel electrophoresis was performed 
with 10% acrylamide according to Laemmli [15]. 
After electrophoresis, proteins were revealed by 
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silver staining [ 161. Bovine serum albumin 
(67 kDa), ovalbumin (43 kDa), carbonic anhy- 
drase (30 kDa) and trypsin inhibitor (20 kDa) were 
used as molecular mass markers. 
3. RESULTS AND DISCUSSION 
The isolation of IDF45 is shown in fig.1. Two 
peaks of inhibitory activity were observed when 
macromolecules (soluble in 1 M acetic acid) of 
medium conditioned by 3T3 cells were fractionated 
by Bio-Gel P150 chromatography (fig. IA). One 
peak, which eluted like ovalbumin (fractions 
IS-18), was enriched in IDF45. The other peak 
(fractions ll-13), of larger molecular mass, was 
not studied further. Fractions 15-18 were pooled 
and used for further purification by reverse-phase 
FPLC. In each experiment, two peaks of in- 
hibitory activity were observed (fig.lB). The first, 
peak I (fractions 13-I6), eluted at about 26% 
acetonitrile; another, peak II (fractions 18, 19), 
which eluted at 29% acetonitrile, was more or less 
abundant depending on the experiments. SDS- 
PAGE of the different fractions showed that the 
inhibitory activity of peak I coincided with the 
presence of a 46-kDa protein band, whereas the in- 
hibitory activity of peak II coincided with a 
30-kDa protein band (not shown). Fractions 
(13,14) which eluted at 26% acetonitrile were 
pooled and used for further purification by 
another reverse-phase FPLC (fig.lC). After this 
final step of purification, about 60 ng/ml of 
IDF45 was necessary to decrease stimulation of 
DNA synthesis by 50% (fig.2) and two protein 
bands (one of 46 kDa) were observed after SDS- 
PAGE (fig.3). It is difficult to assess the degree of 
purification of IDF45, since conditioned medium 
contains different inhibitory molecules [2]. 
However, we have noted that, after the first Bio- 
Gel P150 chromatography, IDF45 activity is con- 
centrated in about 10% of the total protein applied 
to the column. Furthermore after the two reverse- 
phase FPLC, the specific activity of IDF45 was 
multiplied by 1000 compared to its activity after 
Bio-Gel P150 chromatography. 
We know (and have verified) that the stimula- 
tion of DNA synthesis tarts between 12 and 16 h 
after addition of growth factors to quiescent 
cultures of 3T3 cells [17]. Furthermore, the 
presence of growth factors for 8 h in the Gi phase 
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is sufficient to trigger the stimulation of DNA syn- 
thesis [ 17). In experiment A (fig.4a) cr-globulin was 
added for 8 h to the medium in the presence or 
absence of IDF45; then the medium was changed, 
replaced by DME medium without cY-globulin and 
IDF45, and cells were labelled immediately with 
[i4C]thymidine for 16 h. The stimulation of DNA 
synthesis induced by the presence of a-globulin for 
8 h was inhibited by IDF45. Therefore, the 
presence of IDF45 in the Gi phase was sufficient to 
inhibit DNA synthesis in the S phase which im- 
mediately follows the Gi phase. However, when 
IDF45 was in the medium for the first 8 h in the 
presence of cu-globulin and the medium was then 
changed, and replaced by DME medium + CY- 
FRACTION tested for IDF45 inhibition ( -), -4280 t---j. 
fRAcTl0~ 
J 
Fig. 1. IsoIation of IDF45. (A) About 20 mg of 
macromolecules concentrated from conditioned medium 
and solubilized in acetic acid (1 M) were 
chromatographed on a ‘Bio-Gel P 150’ column (22 x 
2.5 cm) packed in 1 M acetic acid. Absorbance at 
280 nm was determined (---). Fractions of 2.7 ml 
were collected, lyophilized and assayed for inhibitory 
activity on DNA synthesis (-). (B) The lyophilized 
fractions (1% 18) from Bio-Gel Pl50 chromatography 
were pooled. About 6OOcg solubilized in TFA (0.05~0) 
were injected on a ProRPC-HR 5/2 column (Pharmacia) 
and eluted as described in section 2. An aliquot of each 
fraction was lyophilized and tested for IDF45 inhibition 
(- ), Azs0 (---). (C) Fractions 13-14 (B) were 
combined, injected into a ProRPC-HR 5/10 column 
(Pharmacia) and- eluted as described in section 2. 
Fractions (0.3 ml) were lyophilized and aliquots were 
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Fig.2. Dose-response curve. Inhibitory fraction 19 from 
the second FPLC chromatography was tested at 
different concentrations for the inhibitory activity of 
DNA synthesis. 
Fig.3. SDS-PAGE of IDF45 purified by two reverse- 
phase FPLC. 
IL 
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Fig.4. Inhibition in the Gr phase of the cell cycle (typical results). In expt A (a), a-globulin was added for 8 h to the 
medium in the presence or absence of IDF45 (40 ng); then the medium was changed and replaced by DME medium 
without a-globulin and IDF45. Cells were labelled immediately for 16 h with [r4C]thymidine. In expt B (a), as in expt 
A, a-globulin and IDF45 were added for the first 8 h, after which the medium was replaced by DME medium with cy- 
globulin, and DNA synthesis was determined between 24 and 48 h after the addition of IDF45 (16-40 h after the change 
in medium). In expt C, (b) IDF45 and a-globulin were added at time 0 and cells labelled with [14C]thymidine, between 
6 and 24 h after the addition of IDF45 and growth factors. In expt D, (b) as in expt C, IDF45 and a-globulin were 
added at times 0 but cells were labelled with [r4C]thymidine between 24 and 48 h after the addition of IDF45 and growth 
factors. Data are means of 3 determinations (f SD). 
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globulin, and DNA synthesis was determined be- 
tween 24 and 48 h after addition of IDF45 
(16-40 h after medium change), inhibition was not 
observed (expt B, fig.4a). Inhibition by IDF45 was 
thus reversible. 
Experiment D (fig.4b) shows that the inhibitory 
effect of IDF45 was observed when inhibitor and 
cu-globulin were present in the medium for 48 h 
and DNA synthesis determined between 24 and 
48 h after their addition. These results suggest hat 
IDF45 is different from ,&TGF, which was in- 
hibitory in the first 24 h after its addition, with cy- 
globulin, to 3T3 cells, but was stimulatory when 
DNA synthesis was determined between 24 and 
48 h after its addition (not shown). 
The experiments (fig.5) also demonstrated that 
IDF45 was effective in the Gi phase of the cell cy- 
cle, since it was able to rapidly decrease the 
stimulation induced by cy-globulin of [14C]inosine 
incorporation into nucleic acids. We have verified 
that this stimulation is not the consequence of a 
change in [i4C]inosine transport, but reflects the 
increase in ribosomal RNA synthesis induced by 
growth factors [ 131. Determination of [i4C]inosine 
incorporation in DNA at different times revealed 
lo. 
5- 
2. 
1. 
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Fig.5. Early inhibition of nucleic acid synthesis (typical 
results). IDF45 (40 ng) and Lu-globulin were added at 
time 0 and cells were labelled with [‘4C]inosine for 2 h 
from 0 to 2 h, 4 to 6 h, 16 to 18 h and 25 to 27 h after 
the addition of cu-globulin + IDF45. [“C]Inosine 
incorporation in acid-insoluble fraction in stimulated 
cells, in the absence (M) or presence (O--O) of 
IDF45. The data are the mean of 3 determinations 
(+ SD). 
that 27 h after the addition of cy-globulin, 90% of 
acid-insoluble 14C radioactivity was incorporated 
into the RNA fraction, but only 10% into DNA. In 
the first 6 h after addition of a-globulin, more 
than 99% of the acid-insoluble radioactivity was 
incorporated into RNA. These experiments thus 
showed that stimulation, in the Gi phase, of RNA 
synthesis was inhibited by the addition of IDF45. 
Since IDF45 had a rather slight effect on 
unstimulated cells compared to its effect on 
stimulated cells, we assumed that IDF45 was not a 
specific inhibitor of RNA synthesis, but rather in- 
hibited one of the early events, induced by growth 
factor addition, which might be responsible for the 
stimulation of RNA synthesis. Further ex- 
periments would be necessary to determine the 
nature of this event. 
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